TrialPF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)
Trial details
- Registry ID
- NCT06602271
- Phase
- Phase 3
ENSC
Ensysce Biosciences
Company identity has not yet been verified
Browse linked trials and recorded changes, or follow this company for updates.
2Trials in this database
3Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)NCT06602271 | Ensysce Biosciences | Phase 3 | Recruiting | 2026-08Estimated |
| Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)NCT06629402 | Ensysce Biosciences | Phase 2 | Completed | 2023-11-14Actual |
Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)
Trial details
- Registry ID
- NCT06629402
- Phase
- Phase 2
Latest recorded trial changes
PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)
NCT06602271 · Ensysce Biosciences
Planned enrollment increased by 20 participants
− Before
300 participants (planned)
+ After
320 participants (planned)
Primary completion date changed
− Before
Mar 2026
+ After
Aug 2026
Recruitment status changed
− Before
Not yet recruiting
+ After
Recruiting